Scientists Develop Cellular ‘Glue’ That Could Change Regenerative Medicine
One group of researchers aims to change this via outside intervention. A team of bioengineers and molecular pharmacologists at the University of California San Francisco have developed what they call a cellular “glue.” The custom-engineered cells have already demonstrated an ability to help scientists direct the way certain cells bond with one another, offering a unique opportunity to orchestrate tissue construction and regeneration.
The team’s study, which was published last week in the journal Nature, describes a process by which they reprogrammed existing cells to take on custom purposes. By combining orthogonal (or one-directional, in this case) molecular interactions outside a cell with native molecular interactions within the cell, the researchers found they were able to utilize the cell’s existing adhesive properties in virtually any way they liked. This ultimately allowed the researchers to control intercellular adhesive interactions.
“The properties of a tissue, like your skin for example, are determined in large part by how the different cells are organized within it,” first author Dr. Adam Stevens said in a statement. “We’re devising ways to control this organization of cells, which is central to being able to synthesize tissues with the properties we want them to have.”
The researchers’ cellular “glue” could have major implications for regenerative medicine, in which tissues and organs are rebuilt or replaced following some type of damage. The nervous system, as stated previously, is notorious for being somewhat of a hopeless cause after trauma or disease. But now that scientists might be able to customize how those cells bind together, there could be hope for restoring function to damaged nervous tissues. The team’s engineering discovery might also facilitate the construction of organs for transplant or disease models for lab research.
Continue reading
AMD Buys FPGA developer Xilinx in $35 Billion Deal
The deal, which we discussed earlier this month, will give AMD access to new markets that it hasn't previously played in, including FPGAs and artificial intelligence.
VIA Technologies, Zhaoxin Strengthen x86 CPU Development Ties
VIA and Zhaoxin are deepening their strategic partnership with additional IP transfers, intended to accelerate long-term product development.
Scientists Develop Nasal Spray That Can Disable Coronavirus
In a newly released study, the concoction was effective at deactivating the novel coronavirus before it could infect cells.
Apple Cuts Fees in Half for App Store Developers Earning Less Than $1 Million
Going forward, Apple's customary 30 percent cut of sales on the iOS platform will drop to just 15 percent for smaller developers. Epic, however, claims this is just an attempt to split the developer community.